Targeting the components of circadian clock has received much attention as a novel approach to treating chronic diseases such as metabolic syndrome, chronic inflammatory diseases and cancer (Roenneberg and Merrow, 2016; Rijo-Ferreira and Takahashi, 2019). Here, CLOCK is linked to cancer.